Arrowhead Research
ARWR • NASDAQ • Stock Fundamentals
Arrowhead Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher R. Anzalone, with a market cap of $10.5B.
Market Cap$10.5B
Employees525.0
CEOChristopher R. Anzalone
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ2 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q3 2026
Financials
Based on Q2 2026 filing
Arrowhead Research FAQ
Common questions about Arrowhead Research
Arrowhead Research (ARWR) has a market capitalization of $10.5B and trades on NASDAQ.
Arrowhead Research has approximately 525 employees.